BRWA
BMRN icon

B. Riley Wealth Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

B. Riley Wealth Advisors’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,341
Closed -$228K – 1547
2023
Q1 		$228K Sell
2,341
-281
-11% -$29.1K 0.01% 1227
2022
Q4 		$271K Buy
+2,622
New +$246K 0.01% 1092
2022
Q2 		– Sell
-3,750
Closed -$290K – 1253
2022
Q1 		$290K Sell
3,750
-34
-0.9% -$2.85K 0.01% 1031
2021
Q4 		$335K Sell
3,784
-221
-6% -$18.2K 0.01% 1014
2021
Q3 		$316K Sell
4,005
-307
-7% -$24.2K 0.01% 1013
2021
Q2 		$352K Buy
4,312
+312
+8% +$24.7K 0.01% 937
2021
Q1 		$312K Buy
4,000
+706
+21% +$57.7K 0.01% 972
2020
Q4 		$290K Sell
3,294
-112
-3% -$8.88K 0.02% 771
2020
Q3 		$290K Sell
3,406
-66
-2% -$6.68K 0.02% 722
2020
Q2 		$429K Sell
3,472
-1,955
-36% -$194K 0.03% 507
2020
Q1 		$460K Buy
+5,427
New +$468K 0.04% 413
2019
Q3 		– Sell
-3,030
Closed -$261K – 815
2019
Q2 		$261K Buy
+3,030
New +$259K 0.03% 620
2015
Q1 		– Sell
-131
Closed -$12 – 733
2014
Q4 		$12 Buy
+131
New +$10.9K ﹤0.01% 2770
2014
Q3 		– Sell
-320
Closed -$19.9K – 788
2014
Q2 		$19.9K Buy
+320
New +$19.3K ﹤0.01% 1475

Other funds holding BMRN

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

B. Riley Wealth Advisors's BMRN Position: Q2 2023 in Review

B. Riley Wealth Advisors sold out of BioMarin Pharmaceuticals (BMRN) in Q2 2023, closing a stake of 2,341 shares — an estimated $228K sold.

B. Riley Wealth Advisors first reported a position in BMRN in Q2 2014 and held it in 14 quarters. The position peaked at $460K in Q1 2020. 558 funds tracked by Wall St. Rank hold BMRN as of Q2 2023.

  • B. Riley Wealth Advisors reported no remaining BioMarin Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 2,341 BioMarin Pharmaceuticals shares in Q2 2023, an estimated $228K.
  • B. Riley Wealth Advisors first reported a position in BioMarin Pharmaceuticals in Q2 2014 and held it in 14 quarters.
  • B. Riley Wealth Advisors's BioMarin Pharmaceuticals position peaked at $460K in Q1 2020.
  • 558 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2023.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2023, filed 27 Jul 2023.